These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34894719)

  • 1. Computer-aided classification of MRI for pathological complete response to neoadjuvant chemotherapy in breast cancer.
    Yan S; Peng H; Yu Q; Chen X; Liu Y; Zhu Y; Chen K; Wang P; Li Y; Zhang X; Meng W
    Future Oncol; 2022 Mar; 18(8):991-1001. PubMed ID: 34894719
    [No Abstract]   [Full Text] [Related]  

  • 2. Preliminary results of computer-aided diagnosis for magnetic resonance imaging of solid breast lesions.
    Yu Q; Huang K; Zhu Y; Chen X; Meng W
    Breast Cancer Res Treat; 2019 Sep; 177(2):419-426. PubMed ID: 31203487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
    Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
    Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Texture analysis based on contrast-enhanced MRI can predict treatment response to neoadjuvant chemotherapy of breast cancer].
    Sun SH; Zhou CW; Zhao LY; Zhang RZ; Ouyang H
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):344-349. PubMed ID: 28535650
    [No Abstract]   [Full Text] [Related]  

  • 6. Textural features of
    Cheng L; Zhang J; Wang Y; Xu X; Zhang Y; Zhang Y; Liu G; Cheng J
    Ann Nucl Med; 2017 Aug; 31(7):544-552. PubMed ID: 28646331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-input deep learning architecture for predicting breast tumor response to chemotherapy using quantitative MR images.
    El Adoui M; Drisis S; Benjelloun M
    Int J Comput Assist Radiol Surg; 2020 Sep; 15(9):1491-1500. PubMed ID: 32556920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
    Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
    Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment.
    Bufi E; Belli P; Di Matteo M; Terribile D; Franceschini G; Nardone L; Petrone G; Bonomo L
    Eur J Radiol; 2014 Sep; 83(9):1631-8. PubMed ID: 24938669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of DCE-MRI for early evaluation of pathological complete response to neoadjuvant chemotherapy in resectable primary breast cancer: A single-center prospective study.
    Sun YS; He YJ; Li J; Li YL; Li XT; Lu AP; Fan ZQ; Cao K; Ouyang T
    Breast; 2016 Dec; 30():80-86. PubMed ID: 27652977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI.
    Zhou J; Lu J; Gao C; Zeng J; Zhou C; Lai X; Cai W; Xu M
    BMC Cancer; 2020 Feb; 20(1):100. PubMed ID: 32024483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method.
    Qu YH; Zhu HT; Cao K; Li XT; Ye M; Sun YS
    Thorac Cancer; 2020 Mar; 11(3):651-658. PubMed ID: 31944571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Machine learning with magnetic resonance imaging for prediction of response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
    Liang X; Yu X; Gao T
    Eur J Radiol; 2022 May; 150():110247. PubMed ID: 35290910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Rectal Cancer Response to Neoadjuvant Chemoradiotherapy Using Deep Learning of Diffusion Kurtosis MRI.
    Zhang XY; Wang L; Zhu HT; Li ZW; Ye M; Li XT; Shi YJ; Zhu HC; Sun YS
    Radiology; 2020 Jul; 296(1):56-64. PubMed ID: 32315264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Texture Analysis with 3.0-T MRI for Association of Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Eun NL; Kang D; Son EJ; Park JS; Youk JH; Kim JA; Gweon HM
    Radiology; 2020 Jan; 294(1):31-41. PubMed ID: 31769740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).
    Gampenrieder SP; Peer A; Weismann C; Meissnitzer M; Rinnerthaler G; Webhofer J; Westphal T; Riedmann M; Meissnitzer T; Egger H; Klaassen Federspiel F; Reitsamer R; Hauser-Kronberger C; Stering K; Hergan K; Mlineritsch B; Greil R
    Breast Cancer Res; 2019 Jan; 21(1):19. PubMed ID: 30704493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Metric for Reducing False Positives in the Computer-Aided Detection of Breast Cancer from Dynamic Contrast-Enhanced Magnetic Resonance Imaging Based Screening Examinations of High-Risk Women.
    Levman JE; Gallego-Ortiz C; Warner E; Causer P; Martel AL
    J Digit Imaging; 2016 Feb; 29(1):126-33. PubMed ID: 26293705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Assessment of a Magnetic Resonance Computer-Aided Diagnosis System in the Detection of Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Peng H; Yan S; Chen X; Hu J; Chen K; Wang P; Zhang H; Zhang X; Meng W
    Front Oncol; 2022; 12():784839. PubMed ID: 35311124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary results.
    Abramson RG; Li X; Hoyt TL; Su PF; Arlinghaus LR; Wilson KJ; Abramson VG; Chakravarthy AB; Yankeelov TE
    Magn Reson Imaging; 2013 Nov; 31(9):1457-64. PubMed ID: 23954320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour.
    Kim SY; Cho N; Shin SU; Lee HB; Han W; Park IA; Kwon BR; Kim SY; Lee SH; Chang JM; Moon WK
    Eur Radiol; 2018 Jul; 28(7):2986-2995. PubMed ID: 29380033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.